Anti-epileptic Agent drugs compared
Compare all 27 Anti-epileptic Agent drugs side by side, used for conditions such as bipolar disorder, epilepsy, epilepsy, absence. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is depakote.
Top-rated anti-epileptic agent: 1. Depakote · 2. Fosphenytoin Sodium · 3. Depakote ER
| Drug | Generic | Form | Status | Used for | Safety ratingFDA recall-based | Pharmacy pays |
|---|---|---|---|---|---|---|
| Depakote | Divalproex Sodium | Tablet | Prescription | Bipolar Disorder, Epilepsy | 72/100 | $6 |
| Fosphenytoin Sodium | — | Injectable | Prescription | Seizures, Status Epilepticus | 72/100 | — |
| Depakote ER | Divalproex Sodium | Tablet | Prescription | Bipolar Disorder, Epilepsy | 70/100 | $6 |
| Felbamate | — | Suspension | Prescription | Seizures, Epilepsy, Complex Partial | 70/100 | $31 |
| Lamictal | Lamotrigine | Tablet | Prescription | Bipolar Disorder, Epilepsies, Partial | 70/100 | $4 |
| Lamictal Cd | Lamotrigine | Tablet | Prescription | Bipolar Disorder, Epilepsies, Partial | 70/100 | $4 |
| Lamictal ODT | Lamotrigine | Tablet | Prescription | Bipolar Disorder, Epilepsies, Partial | 70/100 | $4 |
| Mysoline | Primidone | Tablet | Prescription | Epilepsies, Partial, Epilepsy, Tonic-Clonic | 70/100 | $3 |
| Primidone | — | Tablet | Prescription | Epilepsies, Partial, Epilepsy, Tonic-Clonic | 70/100 | $3 |
| Trileptal | Oxcarbazepine | Suspension | Prescription | Epilepsies, Partial | 70/100 | $5 |
| Valproate Sodium | — | Injectable | Prescription | — | 70/100 | — |
| Zonisade | Zonisamide | Suspension | Prescription | Epilepsies, Partial | 70/100 | $3 |
The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.
Best anti-epileptic agent by condition
Full ranking · 27 drugs
- 172/100
depakote
Divalproex Sodium
- 272/100
fosphenytoin sodium
Fosphenytoin Sodium
- 370/100
depakote er
Divalproex Sodium
- 470/100
felbamate
Felbamate
- 570/100
lamictal
Lamotrigine
- 670/100
lamictal cd
Lamotrigine
- 770/100
lamictal odt
Lamotrigine
- 870/100
mysoline
Primidone
- 970/100
primidone
Primidone
- 1070/100
trileptal
Oxcarbazepine
- 1170/100
valproate sodium
Valproate Sodium
- 1270/100
zonisade
Zonisamide
- 1368/100
divalproex sodium
Divalproex Sodium
- 14New
celontin
Methsuximide
- 15New
cerebyx
Fosphenytoin Sodium
- 16New
felbatol
Felbamate
- 17New
gabapentin
Gabapentin
- 18New
gabitril
Tiagabine Hydrochloride
- 19New
gralise
Gabapentin
- 20New
lamictal xr
Lamotrigine
- 21New
lamotrigine
Lamotrigine
- 22New
neurontin
Gabapentin
- 23New
oxtellar xr
Oxcarbazepine
- 24New
sabril
Vigabatrin
Frequently asked questions
What is the Anti-epileptic Agent drug class?
Anti-epileptic Agent is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 27 Anti-epileptic Agent products, each independently rated.
Are all Anti-epileptic Agent drugs the same?
No. Anti-epileptic Agent drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Anti-epileptic Agent drugs treat?
Per NIH RxClass drug-classification data, Anti-epileptic Agent drugs are used for conditions including bipolar disorder, epilepsy, epilepsy, absence, epilepsy, complex partial, seizures, status epilepticus.
Which Anti-epileptic Agent drug is best-rated?
By our independent rating, depakote currently ranks highest among Anti-epileptic Agent drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Sources: the Anti-epileptic Agent class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class); how the class works is summarized from Seizure Medications — StatPearls, NCBI Bookshelf (NIH). Ratings are pharmaranks’ independent FDA recall-safety analysis.